Cerenome

Houston, USA — August 13, 2026 Cerenome, Inc. announced that its wholly owned subsidiary CNSide Diagnostics, LLC has signed...

Houston, Texas, August 14, 2026 Cerenome, Inc. reported continued progress across its integrated central nervous system (CNS) oncology platform,...